{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:33:16Z","timestamp":1790681596890,"version":"4.1.0"},"reference-count":62,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,9,27]]},"DOI":"10.18632\/oncotarget.11503","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T22:12:29Z","timestamp":1471903949000},"page":"63408-63423","source":"Crossref","is-referenced-by-count":87,"title":["Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance"],"prefix":"10.18632","volume":"7","author":[{"given":"Sofia","family":"Avnet","sequence":"first","affiliation":[{"name":"Orthopaedic Pathophysiology and Regenerative Medicine Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lemma","sequence":"additional","affiliation":[{"name":"Orthopaedic Pathophysiology and Regenerative Medicine Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Cortini","sequence":"additional","affiliation":[{"name":"Orthopaedic Pathophysiology and Regenerative Medicine Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Pellegrini","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Perut","sequence":"additional","affiliation":[{"name":"Orthopaedic Pathophysiology and Regenerative Medicine Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Zini","sequence":"additional","affiliation":[{"name":"CNR - National Research Council of Italy, Institute of Molecular Genetics, Bologna, Italy"},{"name":"Laboratory of Musculoskeletal Cell Biology, Istituto Ortopedico Rizzoli, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyuki","family":"Kusuzaki","sequence":"additional","affiliation":[{"name":"Musculoskeletal Oncology Unit, Takai Hospital, Nara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokuhiro","family":"Chano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Grisendi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University-hospital of Modena e Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University-hospital of Modena e Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Milito","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Baldini","sequence":"additional","affiliation":[{"name":"Orthopaedic Pathophysiology and Regenerative Medicine Unit, Istituto Ortopedico Rizzoli, Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment - where do we stand? A state of the art review","volume":"40","author":"Juergens","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1586\/14737140.6.7.1075","article-title":"Chemotherapy resistance in osteosarcoma: current challanges and future directions","volume":"6","author":"Gorlick","year":"2006","journal-title":"Expert Rev Anicancer Ther"},{"key":"3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199511233332103","article-title":"Expression of p-glycoprotein in high-grade osteosarcomas in relation to clinical outcome","volume":"333","author":"Serra","year":"1995","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/nm0497-378","article-title":"Multidrug resistance--a multiplex phenomenon","volume":"3","author":"Baldini","year":"1997","journal-title":"Nat Med"},{"key":"5","first-page":"4570","article-title":"Insulin-like growth factor i receptor-mediated circuit in ewing's sarcoma\/peripheral neuroectodermal tumor: A possible therapeutic target","volume":"56","author":"Baldini","year":"1996","journal-title":"Cancer Res"},{"key":"6","first-page":"1998","article-title":"Analysis of P-glycoprotein expression in osteosarcoma","volume":"31A","author":"Baldini","year":"1995","journal-title":"Eur J Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1002\/cncr.20151","article-title":"Evaluation of p-glycoprotein her-2\/erbb-2 p53 and bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma","volume":"100","author":"Bacci","year":"2004","journal-title":"Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbrc.2009.10.020","article-title":"Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated bcl-2 silencing","volume":"390","author":"Oda","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"9","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1038\/onc.2009.274","article-title":"Mechanism of chemoresistance mediated by mir-140 in human osteosarcoma and colon cancer cells","volume":"28","author":"Ju","year":"2009","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1476-4598-9-96","article-title":"Molecular mechanism of chemoresistance by mir-215 in osteosarcoma and colon cancer cells","volume":"9","author":"Ju","year":"2010","journal-title":"Mol Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/joim.12024","article-title":"The niche under siege: Novel targets for metastasis therapy","volume":"274","author":"Huelsken","year":"2013","journal-title":"J Intern Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"Vegfr1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Wu","year":"2005","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1073\/pnas.1113483108","article-title":"Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation","volume":"108","author":"Semenza","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Giaccia","year":"2009","journal-title":"Cancer Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jcmm.12004","article-title":"Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells","volume":"17","author":"Batra","year":"2013","journal-title":"J Cell Mol Med"},{"key":"16","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/ijc.24601","article-title":"Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3","volume":"125","author":"Kuppusamy","year":"2009","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1634\/theoncologist.12-6-690","article-title":"Review: implications ofresearch on the effect of radiotherapy and chemotherapy under hypoxic conditions","volume":"12","author":"Vermorken","year":"2007","journal-title":"Oncologist"},{"key":"18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jjco\/hyl137","article-title":"Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: Correlation with clinicopathological parameters and survival outcome","volume":"37","author":"Huang","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s11999-008-0328-y","article-title":"Hypoxia markers in human osteosarcoma: An exploratory study","volume":"466","author":"Gorlick","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stem.2010.07.007","article-title":"Oxygen in stem cell biology: a critical component of stem cell niche","volume":"7","author":"Quinones-Hinojosa","year":"2010","journal-title":"Cell Stem Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11914-011-0047-2","article-title":"A central role for hypoxic signaling in cartilage bone and hematopoiesis","volume":"9","author":"Schipani","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/bjc.1991.326","article-title":"Are cancer cells acidic?","volume":"64","author":"Griffiths","year":"1991","journal-title":"Br J Cancer"},{"key":"24","first-page":"6449","article-title":"Blood flow oxygen and nutrient supply and metabolic microenvironment of human tumors: A review","volume":"49","author":"Okunieff","year":"1989","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/02656739509022457","article-title":"Extracellular ph distribution in human tumours","volume":"11","author":"McFarlane","year":"1995","journal-title":"Int J Hyperthermia"},{"key":"26","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1158\/0008-5472.CAN-15-2962","article-title":"Darwinian dynamics of intratumoral heterogeneity: Not solely random mutations but also variable environmental selection forces","volume":"76","author":"Gatenby","year":"2016","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.18632\/oncoscience.123","article-title":"Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach","volume":"2","author":"Calorini","year":"2015","journal-title":"Oncoscience"},{"key":"28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbadis.2013.04.003","article-title":"V-atpase is a candidate therapeutic target for ewing sarcoma","volume":"1832","author":"Baldini","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yexcr.2013.10.011","article-title":"V-atpase as an effective therapeutic target for sarcomas","volume":"320","author":"Baldini","year":"2014","journal-title":"Exp Cell Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0006-2952(03)00467-2","article-title":"Tumor acidity ion trapping and chemotherapeutics I Acid ph affects the distribution of chemotherapeutic agents","volume":"66","author":"Gillies","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"31","first-page":"4373","article-title":"Acid ph in tumors and its potential for therapeutic exploitation","volume":"49","author":"Rotin","year":"1989","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.187.10.1583","article-title":"Defective acidification in human breast tumor cells and implications for chemotherapy","volume":"187","author":"Simon","year":"1998","journal-title":"J Exp Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbadis.2013.01.020","article-title":"The role of proton dynamics in the development and maintenance of multidrug resistance in cancer","volume":"1832","author":"Rauch","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"34","doi-asserted-by":"crossref","first-page":"e21549","DOI":"10.1371\/journal.pone.0021549","article-title":"Regulation of mtorc1 signaling by ph","volume":"6","author":"Roberge","year":"2011","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"30664","DOI":"10.1074\/jbc.M112.339127","article-title":"Autophagy is a protective mechanism for human melanoma cells under acidic stress","volume":"287","author":"De Milito","year":"2012","journal-title":"J Biol Chem"},{"key":"36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"Ait-Si-Ali","year":"2012","journal-title":"Autophagy"},{"key":"37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1158\/0008-5472.CAN-11-2001","article-title":"Hmgb1 promotes drug resistance in osteosarcoma","volume":"72","author":"Tang","year":"2012","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"crossref","first-page":"e110340","DOI":"10.1371\/journal.pone.0110340","article-title":"Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embyonal rhabdomyosarcoma cell line RD","volume":"9","author":"Baldini","year":"2014","journal-title":"PloS one"},{"key":"39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.nucmedbio.2006.07.011","article-title":"Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies","volume":"33","author":"Cleton-Jansen","year":"2006","journal-title":"Nucl Med Biol"},{"key":"40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.106.028167","article-title":"The effect of low pH on breast cancer resistance protein (ABCG2)-mediated trasnport of methotrexate 7-hydroxymethotrexate methotrexate diglutamate folic acid mitoxantrone topotecan and resevratrol indrug transport models","volume":"71","author":"Schellens","year":"2007","journal-title":"Mol Pharmacol"},{"key":"41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Ling","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"42","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/mp200292c","article-title":"Drug resistance and cellular adaptation to tumor acidic ph microenvironment","volume":"8","author":"Gillies","year":"2011","journal-title":"Mol Pharm"},{"key":"43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.1041000103","article-title":"Intracellular ph changes during the cell cycle in tetrahymena","volume":"100","author":"Deamer","year":"1979","journal-title":"J Cell Physiol"},{"key":"44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase ii","volume":"226","author":"Liu","year":"1984","journal-title":"Science"},{"key":"45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0006-2952(99)00021-0","article-title":"Ph and drug resistance Ii Turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs","volume":"57","author":"Gillies","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/002215549704500909","article-title":"Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry","volume":"45","author":"Manfait","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00249-006-0113-3","article-title":"Mutli drug resistance-dependent \u201cvacuum cleaner\u201d functionality potentially driven by the interactions between endocytosis drug size and P-gp trasnporters surface density","volume":"36","author":"Pleun","year":"2007","journal-title":"Eur Biophys J"},{"key":"48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jmr.643","article-title":"Destination \u2018lysosome\u2019: A target organelle for tumour cell killing?","volume":"16","author":"Isidoro","year":"2003","journal-title":"J Mol Recognit"},{"key":"49","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/bbrc.1993.2306","article-title":"Evidence for a common binding site for omeprazole and n-ethylmaleimide in subunit a of chromaffin granule vacuolar-type h(+)-atpase","volume":"196","author":"Futai","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MAJ.0b013e31823e62e5","article-title":"The efficacy of abraxane on osteosarcoma xenografts in nude mice and expression of secreted protein acidic and rich in cysteine","volume":"344","author":"Xu","year":"2012","journal-title":"Am J Med Sci"},{"key":"51","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","article-title":"Enhancement of chemotherapy by manipulation of tumour ph","volume":"80","author":"Gillies","year":"1999","journal-title":"Br J Cancer"},{"key":"52","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/81.9.706","article-title":"Increased cytosolic ph in multidrug-resistant human lung tumor cells: Effect of verapamil","volume":"81","author":"Joenje","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"53","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1021\/bi00092a014","article-title":"Lower electrical membrane potential and altered phi homeostasis in multidrug-resistant (mdr) cells: Further characterization of a series of mdr cell lines expressing different levels of p-glycoprotein","volume":"32","author":"Carlson","year":"1993","journal-title":"Biochemistry"},{"key":"54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1381612003401163","article-title":"What is the precise role of human mdr 1 protein in chemotherapeutic drug resistance?","volume":"6","author":"Roepe","year":"2000","journal-title":"Curr Pharm Des"},{"key":"55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/355830a0","article-title":"Volume-regulated chloride channels associated with the human multidrug-resistance p-glycoprotein","volume":"355","author":"Higgins","year":"1992","journal-title":"Nature"},{"key":"56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1359-6446(98)01276-8","article-title":"Role of organelle ph in tumor cell biology and drug resistance","volume":"4","author":"Simon","year":"1999","journal-title":"Drug Discov Today"},{"key":"57","first-page":"4427","article-title":"Monoclonal antibody mrk16 reverses the multidrug resistance of multidrug-resistant transgenic mice","volume":"52","author":"Pastan","year":"1992","journal-title":"Cancer Res"},{"key":"58","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1479-5876-11-268","article-title":"Proton pump inhibitor chemosensitization in human osteosarcoma: From the bench to the patients' bed","volume":"11","author":"Fais","year":"2013","journal-title":"J Transl Med"},{"key":"59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/abio.1996.0383","article-title":"An acid phosphatase assay for quantifying the growth of adherent and nonadherent cells","volume":"241","author":"Kain","year":"1996","journal-title":"Anal Biochem"},{"key":"60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01209668","article-title":"Adriamycin binding assay: A valuable chemosensitivity test in human osteosarcoma","volume":"119","author":"Campanacci","year":"1992","journal-title":"J Cancer Res Clin Oncol"},{"key":"61","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.2174\/1381612821666150918144953","article-title":"Acridine orange is an effective anti-cancer drug that affects mitochondrial function in osteosarcoma cells","volume":"21","author":"Baldini","year":"2015","journal-title":"Curr Pharm Des"},{"key":"62","first-page":"151","article-title":"Modified protocol for the testing of new synthetics in the l1210 lymphoid leukemia murine model in the dr&d program dct nci","author":"Abbott","year":"1977","journal-title":"Natl Cancer Inst Monogr"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T07:58:58Z","timestamp":1589270338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":62,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016,9,27]]}},"alternative-id":["11503","27566564"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11503","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}